159 related articles for article (PubMed ID: 15780816)
1. Influence of HTLV-2 infection on hepatitis C virus replication in HIV-positive patients.
Toro C; Bassani S; Ríos P; Jiménez V; Camino N; Soriano V
J Clin Virol; 2005 Apr; 32(4):338-9. PubMed ID: 15780816
[No Abstract] [Full Text] [Related]
2. Increased hepatitis C virus load among injection drug users infected with human immunodeficiency virus and human T lymphotropic virus type II.
Hisada M; Chatterjee N; Zhang M; Battjes RJ; Goedert JJ
J Infect Dis; 2003 Sep; 188(6):891-7. PubMed ID: 12964121
[TBL] [Abstract][Full Text] [Related]
3. Perinatal hepatitis C virus transmission--role of human immunodeficiency virus infection and injection drug use.
Armstrong GL; Perz JF; Alter MJ
J Infect Dis; 2003 Mar; 187(5):872; author reply 872-4. PubMed ID: 12599064
[No Abstract] [Full Text] [Related]
4. HTLV infection among young injection and non-injection heroin users in Spain: prevalence and correlates.
de la Fuente L; Toro C; Soriano V; Brugal MT; Vallejo F; Barrio G; Jiménez V; Silva T;
J Clin Virol; 2006 Mar; 35(3):244-9. PubMed ID: 16143565
[TBL] [Abstract][Full Text] [Related]
5. Leprosy and confinement due to leprosy show high association with hepatitis C in Southern Brazil.
de Moraes Braga AC; Reason IJ; Maluf EC; Vieira ER
Acta Trop; 2006 Jan; 97(1):88-93. PubMed ID: 16263074
[TBL] [Abstract][Full Text] [Related]
6. Evidence of multiple hepatitis virus infections in autopsied materials of intravenous drug addicts.
Schleicher S; Schieffer M; Jürgens S; Wehner HD; Flehmig B
Ig Sanita Pubbl; 2005; 61(5):435-50. PubMed ID: 17214028
[TBL] [Abstract][Full Text] [Related]
7. Seroprevalences and co-infections of HIV, hepatitis C virus and hepatitis B virus in injecting drug users in Quetta, Pakistan.
Achakzai M; Kassi M; Kasi PM
Trop Doct; 2007 Jan; 37(1):43-5. PubMed ID: 17326891
[TBL] [Abstract][Full Text] [Related]
8. High prevalence of genotype 4 among hepatitis C virus-infected intravenous drug users in north-eastern Poland.
Chlabicz S; Flisiak R; Kowalczuk O; Wiercińska-Drapalo A; Pytel-Krolczuk B; Prokopowicz D; Chyczewski L
J Med Virol; 2008 Apr; 80(4):615-8. PubMed ID: 18297715
[TBL] [Abstract][Full Text] [Related]
9. Molecular and cellular interactions of HIV-1/HTLV coinfection and impact on AIDS progression.
Casoli C; Pilotti E; Bertazzoni U
AIDS Rev; 2007; 9(3):140-9. PubMed ID: 17982939
[TBL] [Abstract][Full Text] [Related]
10. Relationship between human T lymphotropic virus (HTLV) type 1/2 viral burden and clinical and treatment parameters among patients with HIV type 1 and HTLV-1/2 coinfection.
Beilke MA; Traina-Dorge VL; Sirois M; Bhuiyan A; Murphy EL; Walls JM; Fagan R; Winsor EL; Kissinger PJ
Clin Infect Dis; 2007 May; 44(9):1229-34. PubMed ID: 17407044
[TBL] [Abstract][Full Text] [Related]
11. Coinfection by human immunodeficiency virus, hepatitis B virus and hepatitis C virus in injecting drug users.
Devi KhS; Singh NB; Singh HL; Singh YM
J Indian Med Assoc; 2009 Mar; 107(3):144, 146-7. PubMed ID: 19810379
[TBL] [Abstract][Full Text] [Related]
12. Possible compartmentalization of hepatitis C viral replication in the genital tract of HIV-1-coinfected women.
Minosse C; Calcaterra S; Abbate I; Selleri M; Zaniratti MS; Capobianchi MR
J Infect Dis; 2006 Dec; 194(11):1529-36. PubMed ID: 17083037
[TBL] [Abstract][Full Text] [Related]
13. High hepatitis C virus viral load in HIV/hepatitis C virus-co-infected patients: a different influence of protease inhibitor and non-protease inhibitor-based HAART?
Bani-Sadr F; Goderel I; Morand P; Payan C; Lunel F; Pol S; Perronne C; Carrat F; Cacoub P
AIDS; 2007 Jul; 21(12):1645-8. PubMed ID: 17630563
[TBL] [Abstract][Full Text] [Related]
14. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in European HIV-infected patients with anti-HCV antibodies.
Pascual Pareja JF; Montes ML; González-García J; Arribas JR
J Infect Dis; 2009 May; 199(10):1556-7; author reply 1557. PubMed ID: 19392631
[No Abstract] [Full Text] [Related]
15. Liver injury and changes in hepatitis C Virus (HCV) RNA load associated with protease inhibitor-based antiretroviral therapy for treatment-naive HCV-HIV-coinfected patients: lopinavir-ritonavir versus nelfinavir.
Sherman KE; Shire NJ; Cernohous P; Rouster SD; Omachi JH; Brun S; Da Silva B
Clin Infect Dis; 2005 Oct; 41(8):1186-95. PubMed ID: 16163639
[TBL] [Abstract][Full Text] [Related]
16. Seroprevalence of viral hepatitis and infectious complications among human immunodeficiency virus-infected injection drug users at a referral hospital.
Liang SH; Lo YC; Lin HH; Chang SY; Chen MY; Hsieh SM; Sheng WH; Sun HY; Hung CC; Chang SC
J Microbiol Immunol Infect; 2008 Jun; 41(3):200-8. PubMed ID: 18629414
[TBL] [Abstract][Full Text] [Related]
17. [Epidemiology of hepatitis C virus infection and circulating genotypes in the Sfax region--Tunisia].
Karray-Hakim H; Goudeau A; Fki-Berrajah L; Hammami A
Tunis Med; 1999 Mar; 77(3):139-44. PubMed ID: 10392032
[No Abstract] [Full Text] [Related]
18. Pattern of hepatitis C virus genotypes in HIV infected patients in RIMS, Hospital, Imphal, Manipur.
Pukhrambam PD; Singh NB; Singh LH; Devi KhS
J Commun Dis; 2007 Mar; 39(1):21-4. PubMed ID: 18338712
[TBL] [Abstract][Full Text] [Related]
19. Spontaneous viral clearance, viral load, and genotype distribution of hepatitis C virus (HCV) in HIV-infected patients with anti-HCV antibodies in Europe.
Soriano V; Mocroft A; Rockstroh J; Ledergerber B; Knysz B; Chaplinskas S; Peters L; Karlsson A; Katlama C; Toro C; Kupfer B; Vogel M; Lundgren J;
J Infect Dis; 2008 Nov; 198(9):1337-44. PubMed ID: 18767985
[TBL] [Abstract][Full Text] [Related]
20. Co-infection by human immuno deficiency virus, hepatitis B and hepatitis C virus in injecting drug users.
Devi KhS; Brajachand N; Singh HL; Singh YM
J Commun Dis; 2005 Mar; 37(1):73-7. PubMed ID: 16637404
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
